The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.
The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.
复制标题
mTOR 和 p-mTOR 对非小细胞肺癌生存的预后作用:系统评价和荟萃分析。
DOI:
10.1371/journal.pone.0116771
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Li WM
中科院分区:
文献类型:
--
作者:
Li L;Liu D;Qiu ZX;Zhao S;Zhang L;Li WM
The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) are potential prognostic markers and therapeutic targets for non-small cell lung cancer (NSCLC). However, the association between mTOR/p-mTOR expression and NSCLC patients’ prognosis remains controversial. Thus, a meta-analysis of existing studies evaluating the prognostic role of mTOR/p-mTOR expression for NSCLC was conducted. A systemically literature search was performed via Pubmed, Embase, Medline as well as CNKI (China National Knowledge Infrastructure). Studies were included that reported the hazard ratio (HR) and 95%CI for the association between mTOR/p-mTOR expression and NSCLC patients’ survival. Random-effects model was used to pool HRs. Ten eligible studies were included in this meta-analysis, with 4 about m-TOR and 7 about p-mTOR. For mTOR, the pooled HR of overall survival (OS) was 1.00 (95%CI 0.5 to 1.99) by univariate analysis and 1.22 (95%CI 0.53 to 2.82) by multivariate analysis. For p-mTOR, the pooled HR was 1.39 (95%CI 0.97 to 1.98) by univariate analysis and 1.42 (95%CI 0.56 to 3.60) by multivariate analysis. The results indicated that no statistically significant association was found between mTOR/p-mTOR expression and NSCLC patients’ prognosis.
登录
查看更多内容
影响因子:
5.6
作者:
Pópulo H;Lopes JM;Soares P
通讯作者:
Soares P
影响因子:
5.5
作者:
Karachaliou N;Rosell R
通讯作者:
Rosell R
影响因子:
6.2
作者:
Liu, Dan;Huang, Yi;Li, Weimin
通讯作者:
Li, Weimin
影响因子:
20.4
作者:
Dhillon, Tony;Mauri, Francesco A.;Seckl, Michael J.
通讯作者:
Seckl, Michael J.
影响因子:
11.5
作者:
Anagnostou, Valsamo K.;Bepler, Gerold;Rimm, David L.
通讯作者:
Rimm, David L.